CRISPR Thx’ Founder: “We have over $250M in the bank”

01/06/2016 - 2 minutes

So begins our series of videos documenting our biotech conference premier – Labiotech Refresh. Here Philip spoke with Rodger Novak, the CEO and founder of CRISPR Therapeutics, which is leading the biotech front on Gene Editing in Europe.

Having the CEO of CRISPR Therapeutics come and speak at our first event was really exciting for us, especially given how CRISPR is such a hot area at the moment.

Please accept preferences cookies to watch this video.

CRISPR is a real revolution in Biotech and gene editing. It’s even considered by many as the discovery of the century and should soon get the Nobel prize. This extremely powerful technology is also moving toward translation into therapeutics.

Therefore, getting to chat with Rodger meant we had a chance to ask these well needed questions, which many are wanting the answers to. For example, what is his stance on germline editing (a contentious area for the field)?

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
Do you want to remove this advert? Become a member!
Do you want to remove this advert? Become a member!

You might also be interested in the following:

Support Us

Become a Member